30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Sweden Biotechnology & Medical Research

Modus Therapeutics Holding AB (MODTX)

Track

The most recent insider trading activity occurred on September 1, 2025. Significant buying activity was noted, with the CEO and other executives making substantial purchases. This contrasts with some earlier selling activity by the CEO in late August 2025. The last transaction prior to this recent buying surge was in December 2021.
Stock chart
Ticker: MODTX Exchange: STO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Viktor, Johan, John Drovta, Dighed, Öhd
Chief Executive Officer (CEO)/Managing Directory, Deputy CEO/Deputy Managing Director, Other member of the company's administrative, management or supervisory body
1 purchase — total 15,408,329 SEK
Buy 1 Sep 2025
Value SEK4,811,395.47 | Price 458.64 | Shares 4,740
Through Karolinska Development AB, a closely affiliated person
Buy 27 Aug 2025
Value SEK2,660,717.59 | Price 175.29 | Shares 37,636
Sale 20 Aug 2025
Value SEK346,080.15 | Price 0.65 | Shares 532,431
Sale 19 Aug 2025
Value SEK249,917.40 | Price 0.90 | Shares 277,686
Buy 1 Dec 2021
Value SEK13,410.00 | Price 4.47 | Shares 3,000
Buy 20 Jul 2021
Value SEK49,996.80 | Price 6.40 | Shares 7,812
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-01 2025-09-01 B Purchase
Viktor, Johan, John Drovta, Dighed, Öhd

Chief Executive Officer (CEO)/Managing Directory, Deputy CEO/Deputy Managing Director, Other member of the company's administrative, management or supervisory body

Through Karolinska Development AB, a closely affiliated person
4,740
458.64
SEK4,811,395 		4,740 458.64 SEK4,811,395
2025-08-28 2025-08-27 B Purchase
John Öhd

Chief Executive Officer (CEO)/Managing Directory

Officer
37,636
175.29
SEK2,660,718 		37,636 175.29 SEK2,660,718
2025-08-21 2025-08-20 S Sale
John Öhd

Chief Executive Officer (CEO)/Managing Directory

Officer
28,205
448.77
SEK4,362,154 		28,205 448.77 SEK4,362,154
2025-08-21 2025-08-19 S Sale
John Öhd

Chief Executive Officer (CEO)/Managing Directory

Officer
277,686
0.90
SEK249,917 		277,686 0.90 SEK249,917
2021-12-01 2021-12-01 B Purchase
Claes Lindblad

Chief Financial Officer (CFO)

Officer
3,000
4.47
SEK13,410 		3,000 4.47 SEK13,410
2021-07-21 2021-07-20 B Purchase
Claes Lindblad

Chief Financial Officer (CFO)

Officer
7,812
6.40
SEK49,997 		7,812 6.40 SEK49,997
Explore more

More insider trading research around Modus Therapeutics Holding AB

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe